Dinner Speech.- Program Director, Multicenter Cooperative Study of the Pathobiological Determinants of Atherosclerosis in Youth, The University of Chicago, USA.- Greetings.- Präsident der Rheinisch-Westfälischen Akademie der Wissenschaften, Düsseldorf.- Dekanin der Medizinischen Fakultät der Westfälischen Wilhelms-Universität Münster.- Ratsherr der Stadt Münster.- Verwaltungsdirektor der Kliniken und der Medizinischen Institute der Westfälischen Wilhelms-Universität Münster.- Vorstand der Gesellschaft für Arterioskleroseforschung e. V. Münster.- em. Direktor der Medizinischen Klinik und Poliklinik der Westfälischen Wilhelms-Universität Münster Ehrenvorsitzender des Instituts für Arterioskleroseforschung an der Universität Münster.- Session I: Arterial Wall and Blood Cell Interactions in the Pathogenesis of Arteriosclerosis.- 1 The Biochemical Basis of Atherosclerosis: Roles for Cytokines.- 2 The Role of T Lymphocate Activation in Arteriosclerosis and Vascular Inflammation.- 3 Platelets and Atherosclerosis - Experimental and Clinical Studies - (Abstract).- 4 The Role of Type 1 Plasminogen Activator Inhibitor in the Regulation of the Fibrinolytic System of the Normal and Atherosclerotic Vessel Wall.- Session II: Disorders in Mesenchymal Cells in the Early Phase of Atherogenesis.- 5 The Cell Populations and other Components of the Atheromatous Lesions in Young People - A Preliminary Report.- 6 Differentiation and Role of Macrophages in the Early Human Atherosclerotic Plaque.- 7 Atherogenic Factors of Blood: Desialylated LDL and Anti-LDL Autoantibodies.- 8 Role of Lipoprotein Receptors on Macrophages in Atherogenesis.- 9 Participation of Leukocytes in the Development of Experimentally Induced Arteriosclerotic Lesions - Morphological and Functional Aspects.- 10 The Value of Co-Culture Systems in Arteriosclerosis Research.- Session III: Hormonal Disorders and Signal Transduction in the Pathogenesis of Arteriosclerosis.- 11 Local Hormones and the Atherogenic Uptake of Low Density Lipoprotein in vivo.- 12 Oral Contraceptive Steroids and Arteriosclerosis.- 13 Parathormone, Calcium Imbalance and Atherogenesis.- Session IV: Therapie und Prävention von Folgeerkrankungen Nach Herzinfarkt.- 14 Nicht-medikamentöse Therapie von ventrikulären Tachyarrhythmien.- 15 Folgezustände nach Herzinfarkt.- 16 Grenzprobleme zwischen chirurgischer und internistischer Therapie bei Koronarkranken.- 17 Verhütung und Behandlung mentaler Risikofaktoren vor und nach Herzinfarkt.- Poster Presentations.- Effects of oral treatment of SHR with enalapril and hydrochlorothiazide. (A light- and electronen-microscopical study).- Transplant Arteriopathy. Similarities to atherosclerosis in morphology, immunohistochemical characterization of cells and distribution of apolipoproteins.- Giant cells in the endothelial layer indicate persistent injury and are a heterogenous subpopulation.- Characterisation of a-Adrenoceptors of Porcine Aorta: differences between vascular smooth muscle and cultured vascular wall cells.- Comparison of several HDL parameters in discriminating between subjects with different risk for myocardial infarction.- Lipid-Lowering theraphy with garlic tablets, comparison with other lipid-lowering drugs.- Cardiac stress in everyday life versus during coronary group therapy.- The thrombocyte function inhibiting effect of garlic: a randomized, placebo-controlled, double-blind parallel group investigation.- Prevalence of autoantibodies to glycated LDL in diabetic and normal subjects.- Foam cells of early atherosclerosis: are they macrophages or smooth muscle cells?.- Quantitative determination of total cholesterol, free cholesterol and different cholesteryl esters in serum samples using RP-HPLC and UV-detection.- Pattern of fatty acids in childhood and the consequences of an unfavourable nutrition in newborns for the cardiovascular risk in later life.- Differential regulation of collagen synthesis and collagenase activity in cultured smooth muscle cells by growth factors.- Influence of type I and type II collagen on the biosynthetic properties of vascular smooth muscle cells.- In situ localization of apolipoproteins A1, A2 and B in arteriosclerotic vessels.